MEN1 and multiple endocrine neoplasia type 1: miR-24 has been demonstrated to negatively regulate menin expression in the parathyroids and the endocrine pancreas in MEN1 syndrome, and in other non-MEN1 sporadic tumors, suggesting it as initiator of menin loss-derived tumorigenesis.